CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-03 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −109 | $7.48 | $815 | 31,827 |
| 2025-04-02 | Young Alethia Chief Financial Officer | Sale | −215 | $8.02 | $2K | 45,390 |
| 2025-04-02 | Skynner Michael CHIEF TECHNOLOGY OFFICER | Sale | −814 | $8.02 | $7K | 122,908 |
| 2025-04-02 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −2,237 | $8.02 | $18K | 489,697 |
| 2025-04-02 | Milnes Alistair CHIEF OPERATING OFFICER | Sale | −1,133 | $8.02 | $9K | 98,655 |
| 2025-04-02 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Sale | −467 | $8.02 | $4K | 54,813 |
| 2025-04-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −210 | $8.02 | $2K | 31,936 |
| 2025-03-25 | Riva Alessandro Director | Grant or award | +12,500 | 12,500 | ||
| 2025-03-25 | Riva Alessandro Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-03-25 | Westin Eric Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +58,000 | 58,000 | ||
| 2025-01-06 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −2,686 | $15.00 | $40K | 32,146 |
| 2025-01-03 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −159 | $14.75 | $2K | 34,832 |
| 2025-01-03 | Crockett Nigel CHIEF BUSINESS OFFICER | Sale | −936 | $14.75 | $14K | 51,053 |
| 2025-01-03 | Milnes Alistair CHIEF OPERATING OFFICER | Sale | −936 | $14.75 | $14K | 99,788 |
| 2025-01-03 | Skynner Michael CHIEF TECHNOLOGY OFFICER | Sale | −936 | $14.75 | $14K | 123,722 |
| 2025-01-03 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Sale | −239 | $14.75 | $4K | 55,280 |
| 2025-01-03 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −3,092 | $14.75 | $46K | 491,934 |
| 2025-01-02 | Legault Pierre Director | Grant or award | +12,500 | 46,000 | ||
| 2025-01-02 | Legault Pierre Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-01-02 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Grant or award 10b5-1 | +17,500 | 36,741 |
Page 7 of 26 · 520 trades